Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear
Launched by OTICON MEDICAL · Mar 15, 2021
Trial Information
Current as of June 08, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subjects who have consented to Section 3 of the document: "GDPR - what this means to you" (Appendix A) as part of a clinical routine visit.
- • 2. Fitted unilaterally or bilaterally with the Ponto 3 SuperPower(s) on abutment(s)
- • 3. Adult subjects (18 years or older)
- • 4. Patient has attended a clinical routine visit where fitting of Ponto 3 SuperPower has been performed and at least one following clinical routine visit where audiological measurements has been performed
- Exclusion Criteria:
- • There are no exclusion criteria in this study due to the retrospective nature of the study.
- • -
About Oticon Medical
Oticon Medical is a leading global innovator in the field of hearing solutions, dedicated to improving the quality of life for individuals with hearing loss. As a subsidiary of the well-established Oticon brand, Oticon Medical specializes in the development and manufacture of advanced auditory devices, including bone-anchored hearing systems and implantable solutions. Committed to research and development, the company actively sponsors clinical trials to evaluate the efficacy and safety of its products, ensuring that cutting-edge technology continues to meet the evolving needs of patients and healthcare professionals. With a focus on evidence-based practices, Oticon Medical strives to enhance auditory experiences and foster better communication for those affected by hearing impairment.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Norwich, , United Kingdom
Norwich, Norfolk, United Kingdom
Patients applied
Trial Officials
John E FitzGerald, Bsc Phd
Principal Investigator
Norfolk & Norwich University Hospital NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials